Illumina Inc. (ILMN) Stock Price Up 2.1%
Shares of Illumina Inc. (NASDAQ:ILMN) rose 2.1% on Friday . The company traded as high as $174.00 and last traded at $173.09, with a volume of 531,490 shares. The stock had previously closed at $169.48.
ILMN has been the topic of a number of research reports. Morgan Stanley cut Illumina from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $130.00 to $110.00 in a research report on Tuesday, July 5th. CL King cut Illumina from a “buy” rating to a “neutral” rating in a research report on Monday, August 22nd. Vetr upgraded Illumina from a “strong sell” rating to a “sell” rating and set a $155.68 price target on the stock in a research report on Monday, August 1st. JPMorgan Chase & Co. increased their price target on Illumina from $185.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 27th. Finally, Zacks Investment Research cut Illumina from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and eleven have issued a buy rating to the company’s stock. Illumina has an average rating of “Hold” and a consensus price target of $165.65.
The company has a market cap of $25.25 billion and a P/E ratio of 58.98. The firm’s 50-day moving average is $161.17 and its 200-day moving average is $151.38.
Illumina (NASDAQ:ILMN) last issued its earnings results on Tuesday, July 26th. The life sciences company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.73 by $0.13. During the same quarter in the previous year, the firm posted $0.80 EPS. The business had revenue of $600 million for the quarter, compared to the consensus estimate of $31.91 million. The business’s revenue was up 11.3% on a year-over-year basis. Equities research analysts anticipate that Illumina Inc. will post $3.53 EPS for the current year.
In other news, EVP Christian O. Henry sold 2,141 shares of the business’s stock in a transaction on Wednesday, June 15th. The shares were sold at an average price of $137.90, for a total value of $295,243.90. Following the completion of the transaction, the executive vice president now owns 20,213 shares of the company’s stock, valued at approximately $2,787,372.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Karin Eastham sold 5,000 shares of the business’s stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $145.35, for a total transaction of $726,750.00. Following the completion of the transaction, the director now directly owns 17,424 shares of the company’s stock, valued at approximately $2,532,578.40. The disclosure for this sale can be found here.
An institutional investor recently bought a new position in Illumina stock. State of Tennessee Treasury Department purchased a new stake in shares of Illumina Inc. (NASDAQ:ILMN) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 95,205 shares of the life sciences company’s stock, valued at approximately $18,274,000. State of Tennessee Treasury Department owned 0.07% of Illumina at the end of the most recent reporting period.
Illumina, Inc (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company’s products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company’s customers include genomic research centers, academic institutions, government laboratories and hospitals, as well as pharmaceutical, biotechnology, agrigenomics and commercial molecular diagnostic laboratories, and consumer genomics companies.